"The weight of evidence indicates that,
although fluoride might increase bone volume, there is less strength
per unit volume."
SOURCE: National Research Council. (2006).
Fluoride
in Drinking Water: A Scientific Review of EPA's Standards.
National Academies Press, Washington D.C. p5.
"The evidence suggests that NaF-induced
BMD increases may be associated with increased fracture risk..."
SOURCE: Gutteridge DH, et al. (2002). A randomized trial of sodium
fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral
fractures: increased vertebral fractures and peripheral bone loss
with sodium fluoride; concurrent estrogen prevents peripheral
loss, but not vertebral fractures. Osteoporosis International
13(2):158-70.
"In this meta-analysis we found that fluoride
increased BMD without showing efficacy on the incidence vertebral
fracture."
SOURCE: Haguenauer D, et al. (2000). Fluoride for the treatment
of postmenopausal osteoporotic fractures: a meta-analysis. Osteoporosis
International 11(9):727-38.
"In conclusion, a BMD increase does not
always produce an increase in bone strength in the fluoride-treated
bone."
SOURCE: Giavaresi G, et al. (1999). The mechanical properties
of fluoride-treated bone in the ovariectomized rat. Calcified
Tissue International 65: 237-241.
"Increases in bone mass resulting from
fluoride treatment did not lead to increased bone strength. In
fact, many biochemical parameters, namely, vertebral and femoral
fracture stress, and femoral elastic modulus, were negatively
correlated with bone mass. This seems counterintuitive,
however, the bone samples with the highest bone mass also had
the highest fluoride content, and the negative
effect of increased fluoride content on bone strength far overwhelmed
the positive effect of increased bone mass."
SOURCE: Turner CH, et al. (1997). Fluoride treatment increased
serum IGF-1, bone turnover, and bone mass, but not bone strength,
in rabbits. Calcified Tissue International 61:77-83.
"The discrepancy that an increase in bone
mass and geometric properties in both trabecular and cortical
bones by low-dose, long term NaF (sodium fluoride) treatment did
not increase vertebral strength nor proportionally improve femoral
strength indicated that the bone intrinsic biomechanical
properties could be changed by NaF treatment."
SOURCE: Jiang Y, et al. (1996). Effects of low-dose long-term
sodium fluoride preventive treatment on rat bone mass and biomechanical
properties. Calcified Tissue International 58:30-9.
In the fluoride-treated animals "bone
strength.... did not increase with bone volume, suggesting that
for bones with higher volume, there was less strength per unit
volume, that is, a deterioration in bone 'quality.'"
SOURCE: Lafage MH, et al. (1995). Comparison of alendronate and
sodium fluoride effects on cancellous and cortical bone in minipigs:
a one year study. Journal of Clinical Investigations 95:
2127-2133.
"It is concluded that the increase in
bone mass during fluoride treatment does not translate into an
improved bone strength and that the bone quality declines."
SOURCE Sogaard CH, et al. (1995). Effects of fluoride on rat vertebral
body biomechanical competence and bone mass. Bone 16: 163-9.
"bone fluoride content was positively correlated with femoral
bone density; however, the increased bone density
was not associated with increased bone strength."
SOURCE: :Turner CH, et al. (1995). Fluoride reduces bone strength
in older rats. Journal of Dental Research 74: 1475-1481.
"again, if bone formed during fluoride
therapy is of poor quality, neither increased mass nor increased
trabecular thickness would directly translate into increased strength."
SOURCE: Sogaard CH, et al. (1994). Marked decrease in trabecular
bone quality after five years of sodium fluoride therapy--assessed
by biomechanical testing of iliac crest bone biopsies in osteoporotic
patients. Bone 15: 393-99.
"fluoride treatment seems to be an intriguing
example, in which bone mineral density (BMD) measurements do not
at all correlate with the biomechanical properties of bone. Consequently,
BMD data from clinical studies without exact
analysis of antifracture effectiveness are useless for assessment
of the risk-benefit ratio of fluoride treatment."
SOURCE: Fratzl P, et al. (1994). Abnormal bone mineralization
after fluoride treatment in osteoporosis: a small-angle x-ray-scattering
study. Journal of Bone and Mineral Research 9:1541-9.
"[T]he large increase in the mineral density
of cancellous (trabecular) bone in the vertebrae during fluoride
treatment did not result in a significant reduction in the rate
of vertebral fracture..."
SOURCE: Riggs BL, et al. (1990). Effect of Fluoride treatment
on the Fracture Rates in Postmenopausal Women with Osteoporosis.
New England Journal of Medicine 322:802-809.
"[A]lthough the risk of fractures normally rises as the
bone mass declines, increases in bone mass with
fluoride treatment may not reduce fracture rates."
SOURCE: Lindsay R. (1990). Fluoride and bone: quantity versus
quality (editorial). New England Journal of Medicine 322:
845-846.
"Due to possible adverse influences of fluoride on the mineralized
tissue physical characteristics... the increase in bone mass does
not necessarily result in an increase in bone strength... [W]e
wish to emphasize the fact that it can be very misleading to rely
on simple measures of bone volume fracture and/or bone density
as indicators of bone strength in fluoride treated patients."
SOURCE: Carter DR, Beaupre GS. (1990). Effects of fluoride treatment
on bone strength. Journal of Bone and Mineral Research
5(Suppl) 1:S177-84.
"It has been proposed that the positive
effect of fluoride on bone mass might have a corresponding effect
on bone strength. This assumption, however, could not be demonstrated
in the present study: the biophysical parameters were found
to be reduced (normalized compressive strength) or unchanged (maximum
compressive strength, stiffness, and energy absorption capacity)
after fluoride treatment in spite of the significant increase
in trabecular bone density."
SOURCE: Mosekilde L, et al. (1987). Compressive strength, ash
weight, and volume of vertebral trabecular bone in experimental
fluorosis in pigs. Calcified Tissue Research 40: 318-322.
"whereas the bone may appear more dense
radiologically, it may, in fact, be more fragile and more susceptible
to fracture. Our findings of a highly significant increase in
fractures in the high fluoride exposure group suggests that this
may indeed be the case."
SOURCE: Carnow BW, Conibear SA. (1981). Industrial fluorosis.
Fluoride 14: 172-181.
"the increase in bone mass that occurrs
after therapy cannot necessarily be equated with an increase in
bone strength."
SOURCE: Riggs BL, et al. (1980). Treatment
of primary osteoporosis with fluoride and calcium: Clinical tolerance
and fracture occurrence. Journal of the American Medical Association
243: 446-449.
"Our observations corroborate the findings that, in general,
elevated dietary fluoride results in an acceleration of bone mineralization.
Uniquely, however, the increase in mineralization
was accompanied by a decrease in bone strength... the changes
in bone that occur with prolonged and excessive fluoride ingestion
may result in a reduction of bone strength."
SOURCE: Chan MM, et al. (1973). Effect of Fluoride on Bone Formation
and Strength in Japanese Quail. Journal of Nutrition 103:
1431-1440.
"The practical issue one is faced with in attempting to
access the therapeutic effect of sodium fluoride is entirely different
than that with any other form of treatment of osteoporosis. This
is because, in the case of every other currently used method of
treatment, there is a high presumption that bone formed during
the period of treatment is of good quality and, therefore, that
if an increased bone mass were demonstrated, it could be assumed
that bone strength would be increased. The problem is that there
has not so far been a convincing demonstration that these other
agents cause an increased bone mass. In the
case of fluoride, there is no reasonable doubt that bone mass
can be increased, but the significance of such change is uncertain,
since the histological appearance of fluorotic bone is abnormal
and its physical strength could not be assumed to be normal. Therefore,
it is critical to establish whether the strength of fluorotic
bone is normal, decreased or increased."
SOURCE: Rich C, Feist E. (1970). The action of fluoride on bone.
In: TL Vischer, ed. (1970). Fluoride in Medicine. Hans Huber,
Bern. pp. 70-87.